Previous 10 | Next 10 |
BUFFALO, N.Y., May 24, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, today announced that the Company will participate in the ...
Are These Penny Stocks The Best Ones For Your May Watchlist? As we inch closer toward the second half of May, penny stocks are highly in focus. Some of the most sought-after assets in the stock market right now are biotech penny stocks as well as tech stocks and blockchain pen...
Image source: The Motley Fool. 22nd Century Group (NYSEMKT: XXII) Q1 2021 Earnings Call May 06, 2021 , 10:00 a.m. ET Operator Continue reading For further details see: 22nd Century Group (XXII) Q1 2021 Earnings Call Transcript
Penny Stocks Are Moving Up Right Now, Are These 3 Worth Watching? When it comes to investing in penny stocks, research is very important. In 2021, it is easy to get information with the click of a few buttons. Often those new to penny stocks will overlook research. Research is one o...
22nd Century Group, Inc. (XXII) Q1 2021 Earnings Conference Call May 06, 2021, 10:00 AM ET Company Participants Mei Kuo - Director-Communications and IR Jim Mish - CEO Mike Zercher - President and COO John Franzino - CFO Conference Call Participants Vivien Azer - Cowen James McIlree - Dawson....
22nd Century (XXII): Q1 GAAP EPS of -$0.03 in-line.Revenue of $6.8M (-4.2% Y/Y)Adjusted EBITDA was a $4.4M loss compared to a $3.2M loss last year.Shares -0.74%Press Release For further details see: 22nd Century EPS in-line
Key Business and Financial Highlights 22nd Century is advancing commercial opportunities across $1.3 trillion global addressable markets in tobacco, hemp/cannabis, and a third plant-based franchise. The significant increase in the Company’s share price since reporting...
BUFFALO, N.Y., May 05, 2021 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII ), a leading plant-based biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and hemp/cannabis research, announced today that it is advancing and expanding capabi...
Updated Agreement Extends Exclusive Program to Create Valuable, New Hemp/Cannabis Varieties and Expands Collaboration to Include 22nd Century’s Two Other Plant Franchises Partnerships Will Enable 22nd Century to Accelerate the New Development of Valuable, Commercial Hemp/...
Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step to Reduce Addiction, Improve Quitting, Reduce Youth Initiation and Reduced Disparities; Movement on Nicotine Cap by FDA Expected to be Forthcoming Tangible Action on Menthol Was Anticipate...
News, Short Squeeze, Breakout and More Instantly...
22nd Century Group Inc Company Name:
XXII Stock Symbol:
NYSE Market:
22nd Century Group Inc Website:
Patented, Fully Water Dispersing, Biodegradable Solution for World's Most Littered Item Mocksville, North Carolina--(Newsfile Corp. - July 10, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announce...
Mocksville, North Carolina--(Newsfile Corp. - July 9, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a new agreement for full-scale commercial rollout of its VLN® reduced nicotine cont...
Mocksville, North Carolina--(Newsfile Corp. - June 25, 2024) - 22nd Century Group, Inc. (NASDAQ: XXII), a tobacco products company focused on nicotine harm reduction and contract manufacturing, today announced a $1.5 million reduction in its secured debt via a paydown of the GVB secured promissor...